A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Syros Pharmaceuticals
AstraZeneca
Western Regional Medical Center
Masonic Cancer Center, University of Minnesota
Northwestern University
Dartmouth-Hitchcock Medical Center